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Tobacco smoking is a bladder cancer risk factor and a source of carcinogens that induce DNA damage to urothelial cells. Using
data and samples from 988 cases and 1,004 controls enrolled in the Los Angeles County Bladder Cancer Study and the Shanghai
Bladder Cancer Study, we investigated associations between bladder cancer risk and 632 tagSNPs that comprehensively capture
genetic variation in 28 DNA repair genes from four DNA repair pathways: base excision repair (BER), nucleotide excision repair
(NER), non-homologous end-joining (NHEJ) and homologous recombination repair (HHR). Odds ratios (ORs) and 95% confidence
intervals (CIs) for each tagSNP were corrected for multiple testing for all SNPs within each gene using pACT and for genes within
each pathway and across pathways with Bonferroni. Gene and pathway summary estimates were obtained using ARTP. We
observed an association between bladder cancer and POLB rs7832529 (BER) (pACT 5 0.003; ppathway 5 0.021) among all, and
SNPs in XPC (NER) and OGG1 (BER) among Chinese men and women, respectively. The NER pathway showed an overall association
with risk among Chinese males (ARTP NER p 5 0.034). The XRCC6 SNP rs2284082 (NHEJ), also in LD with SREBF2, showed an
interaction with smoking (smoking status interaction pgene 5 0.001, ppathway 5 0.008, poverall 5 0.034). Our findings support a
role in bladder carcinogenesis for regions that map close to or within BER (POLB, OGG1) and NER genes (XPC). A SNP that tags
both the XRCC6 and SREBF2 genes strongly modifies the association between bladder cancer risk and smoking.
Urinary bladder cancer is among the 10 most common can-
cers worldwide, with its age standardized incidence rate vary-
ing by gender and world regions.1 In Los Angeles County
non-Hispanic white men have the highest incidence rate of
bladder cancer, followed by Hispanic, African-American and
Asian-American men, in spite of comparable profiles of
tobacco use. Women show a similar pattern of incidence
rates by race, although the overall rates are much lower than
men.2 Chinese from Shanghai have about two-third the inci-
dence rate of bladder cancer of Chinese in Los Angeles.3 Cig-
arette smoking and occupational exposure to arylamines are
the main established risk factors.4 Tobacco smoking contrib-
utes upwards of 50% of bladder cancer occurrence in men
and 20% in women5; although more recent data suggests that
in the United States the population attributable risk of smok-
ing among men and women might now be comparable.6 In
addition to smoking and occupational exposure to aryl-
amines,7 use of hair dyes has been identified as a bladder
cancer risk factor.8
Chemical carcinogens present in tobacco smoke, such
as polycyclic aromatic hydrocarbons, aromatic amines,
heterocyclic amines and N-nitroso compounds and aryl-
amines from other sources, can induce DNA damage in
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the bladder epithelium.9 In addition, reactive oxygen spe-
cies (ROS) present in tobacco smoke,10 and also generated
as a by-product of chemical carcinogen metabolism,11,12
can contribute to additional DNA damage. Altogether,
chemical carcinogens and ROS can contribute to the accu-
mulation of bulky adducts, single (SSB) and double strand
breaks (DSB) and various forms of nucleotide base modifi-
cation or loss which can lead to genomic instability. Modi-
fied or lost bases and SSBs are generally repaired through
the base excision repair pathway (BER). DSBs are repaired
by either the non-homologous end joining (NHEJ) or the
homologous recombination repair (HRR) pathways. Bulky
adducts are repaired by the nucleotide excision repair
(NER) pathway.
Given the important role DNA repair pathways play in
maintaining DNA integrity, it has been postulated that inter-
individual genetic variation in these pathways may modify
bladder cancer risk. Consistent with this hypothesis, individu-
als with reduced DNA repair proficiency were reported to
have higher risk of developing bladder cancer.13 Several epi-
demiological studies have investigated the bladder cancer
associations with candidate polymorphisms in selected DNA
repair genes, and a large pooled and meta-analysis of most of
these studies offered support for a role of selected DNA
repair variants in bladder carcinogenesis.14 More recently, a
comprehensive analysis of the NER pathway was conducted
which offered further support for a role for DNA repair var-
iants in bladder cancer risk.15
In this study, we report findings from an extensive
pathway-based examination of 632 haplotype-tagging SNPs
selected to examine common variation in coding and non-
coding regions across 27 DNA repair-related genes, belonging
to four DNA repair pathways: BER (APEX1, LIG3, NEIL1,
OGG1, PARP1, POLB and XRCC1), NER (ERCC1, ERCC2,
ERCC4, ERCC5, LIG1, POLD1, XPA and XPC), NHEJ
(DCLRE1C, LIG4, PRKDC, XRCC4, XRCC5 and XRCC6) and
HRR (MRE11A, NBN, RAD50, RAD51, RAD52, XRCC2 and
XRCC3). We conducted these analyses using data from two
parallel case-control studies that were similarly designed and
carried out in areas of high and low bladder cancer risk: the
Los Angeles Bladder Cancer Study and the Shanghai Bladder
Cancer Study. We considered the potential modifying role of
DNA repair SNPs on the association of gender and smoking
with bladder cancer risk.
Material and Methods
Study population
Study participants were enrolled as part of two population-
based case-control studies of transitional cell carcinoma of the
urinary bladder conducted in Los Angeles County, California,
USA and Shanghai, China. Characteristics of the Los Angeles
Bladder Cancer (LABC) and Shanghai Bladder Cancer (SBC)
studies have been described previously.16,17 Briefly, the Los
Angeles County Cancer Surveillance Program was used to
identify cases diagnosed with histologically confirmed bladder
cancer, among non-Asian cases between the ages of 25 and 68
years of age from 1987 through 1996. Using a standard proce-
dure,16 controls were identified among residents of the cases’
neighborhoods of residence and individually (1:1) matched to
cases by gender, race/ethnicity and age (65 years). In Shang-
hai, the Shanghai Cancer Registry was used to identify cases
diagnosed with histologically confirmed bladder cancer, resi-
dents of the city of Shanghai and between the ages of 25 and 74
years of age from 1995 to 1998. A previously described algo-
rithm was used to randomly identify population-based controls
from within the city of Shanghai,18 who were frequency
matched to bladder cancer cases by gender and five year age
groups. In-person questionnaires administered to all study par-
ticipants were used to collect demographic, lifestyle and medi-
cal characteristics up to the reference date, which in Los
Angeles was defined for each case-control pair as two years
before the case’s diagnosis and in Shanghai was defined as two
years prior to diagnosis for cases and two years prior to inter-
view for controls. Mean time interval between bladder cancer
diagnosis and interview was 11 months for bladder cancer
cases in Los Angeles County, and 7 months for bladder cancer
cases in Shanghai.16,17 Blood specimens were collected at the
time of interview. Analyses in the current study were restricted
to 936 non-Hispanic Whites (NHW) from Los Angeles County
(456 cases and 480 controls) and 1,056 Han Chinese from
Shanghai (532 cases and 524 controls) with DNA and ques-
tionnaire data. The study was approved by Institutional Review
Boards at the University of Southern California, the Shanghai
Cancer Institute and the University of Pittsburgh.
Tagging SNP selection
Tagging SNPs (tagSNPs) for each DNA repair gene region
were selected using Snagger19 based on the HapMap CEPH
What’s new?
DNA repair plays a vital role in maintaining DNA integrity in bladder epithelial cells exposed to carcinogens from tobacco
smoke. As a result, genetic variations in DNA repair genes could modify bladder cancer risk. Here, analysis of 28 genes that
participate in four DNA repair pathways suggests that certain variants in base excision repair and nucleotide excision repair
genes may contribute to bladder cancer formation specifically in Chinese populations. Gene-by-environment interaction analy-
ses that included non-Hispanic whites and Chinese suggest that double strand breaks might be the most detrimental type of
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(Utah residents with Northern and Western European Ances-
try (CEU)) population and Han Chinese in Beijing, China
(CHB), population using data from HapMap release 21, July
2006. TagSNPs were selected using the following criteria:
minor allele frequency (MAF)  5%, pairwise r2  0.80 and
a distance from the closest SNP greater than 60 base pairs on
the Illumina platform. For each gene, the 50-UTR- and 30-
UTR regions were extended to include SNPs 20 kb
upstream and 10 kb downstream. In regions of no or low
LD, tagSNPs with a MAF 5% at a density of 1 per kb
were selected from either HapMap or dbSNP. Finally, non-
synonymous tagSNPs and selected investigator selected SNPs
were included regardless of the MAF. With the tagging
approach used we were able to capture on average 95.6%
(range from 83% to 100%) of genetic variation in CEU and
96.2% (range from 85% to 100%) in CHB, when considering
the HapMap release 21, July 2006. This coverage is likely to
be lower if we considered the more recent 1,000 Genomes as
reference panel.
SNP genotyping and quality control
Peripheral blood lymphocytes were subjected to proteinase K
digestion, phenol-chloroform extraction and ethanol precipi-
tation for the purpose of DNA extraction. SNPs were geno-
typed on the Illumina GoldenGate BeadArray genotyping
platform20 (Illumina, Inc., San Diego, CA, USA) at the
Genomics Core of the USC Norris Comprehensive Cancer
Center. The Bead Studio software program was used to clus-
ter and call genotypes according to standard Illumina proto-
cols. In addition to Illumina QC measures, cases and controls
were mixed on genotyping plates and blinded duplicate sam-
ples were included. The observed concordance for duplicate
samples was >99%. Genotype data from 30 CEPH trios
(Coriell Cell Repository, Camden, NJ) was also used to con-
firm genotyping reliability and reproducibility. TagSNPs were
excluded if more than three discordant genotypes were found
in comparison with genotypes from the International Hap-
Map Project.
Further stringent criteria were applied to ensure quality
genotyping data. We required that all SNPs have call rates
0.90 for the combined LABC-SBC study after eliminating
SNPs which failed completely. Of the 632 SNPs, five SNPs
were eliminated due to call rates of 0%. Supporting Informa-
tion Table 1 describes all 627 SNPs in this study, including
their minor allele frequencies among NHW and Chinese con-
trol populations. Analyses that stratified on race were
restricted to SNPs with MAF 5% among Los Angeles con-
trols (545 SNPs) or SNPs with MAF 5% among Shanghai
controls (542 SNPs). Combined analyses of LABC and SBC
were restricted to SNPs with MAF 5% among controls
from both study sites (469 SNPs). We required all individuals
had overall call rates 90% and excluded from analyses 192
individuals with overall call rates less than 90%. After exclud-
ing subjects with call rates less than 90%, we had genotyping
results available for 1,800 individuals out of a total of 1,992.
Individuals with genotyping data did not differ significantly
from those without genotyping data for key characteristics,
such as those listed in Table 1.
Deviations of observed genotype frequencies from those
expected under Hardy-Weinberg equilibrium (HWE) were
examined among Los Angeles and Shanghai controls sepa-
rately using exact tests. The p-value when testing deviations
of observed genotype frequencies from those expected under
HWE was deemed significant if p < 0.00008 using exact tests
(Bonferroni-corrected p-value; a 5 0.05/627). We did not
observe evidence of deviations of observed from expected val-
ues among Los Angeles non-Hispanic white controls or
Shanghai Chinese controls.
Statistical analysis
SNP main effects. In order to include all available individu-
als in our study, regardless of availability of 1:1 matched con-
trols, we grouped individuals according to their reference age
(<45, 45–49, 50–54, 55–59 and 60 years for Los Angeles
non-Hispanic whites and <45, 45–49, 50–54, 55–59, 60–64
and 65 years for Shanghai Chinese), gender and study site
and used it to group individuals in conditional logistic regres-
sion models used to estimate relative risks with odds ratios
(ORs) and 95% confidence intervals (95% CI). Assuming a
log-additive mode of action, we estimated per-allele ORs and
95% CI for the associations between each tagSNP and blad-
der cancer. Models were adjusted for smoking status (never/
quit/current) in the reference year. Analyses were conducted
separately by study site and jointly with adjustment for study
site; we assessed for potential heterogeneity of SNP main
effects across both study sites using likelihood ratio tests.
Given the observed disparities in bladder cancer incidence
between males and females, both in Los Angeles and Shang-
hai, we hypothesized that different environmental risk factors
could associate with each gender. If some of these risk factors
contribute to bladder carcinogenesis through the accumula-
tion of DNA damage, we speculated that we could observe
different associations between DNA repair SNPs and bladder
cancer for males and females. To test this hypothesis, we
assessed potential heterogeneity of SNP main effects by gen-
der using likelihood ratios tests.
Multiple testing was conducted in a hierarchical bottom-
up manner. We first corrected for multiple SNP tests within
each gene region, then for multiple genes within the corre-
sponding DNA repair pathway, and finally across all four
DNA repair pathways investigated. Specifically, for each SNP
within each gene region, crude p-values (pcrude) were cor-
rected for multiple testing using the PACT (p-value adjusted
for correlated tests) approach implemented within R.21 We
corrected for overall significance across gene regions within
each pathway (ppathway) using a Bonferroni correction of the
PACT corrected p-value. Finally, we further corrected for over-
all statistical significance across all four investigated pathways
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Pathway analyses. In order to capture gene and pathway
level effects that may not be detectable through any single
SNP, we performed gene-based and pathway-based tests
using the Adaptive Rank-Truncated Product (ARTP)
method.22 ARTP adaptively combines single SNP p-values
within a gene region or a pathway to obtain a single test sta-
tistic for the gene or pathway and assesses significance of the
test via a permutation procedure. Unlike a multiple testing
procedure like PACT, which accounts for multiple SNP tests
in order to properly control the type I error, ARTP combines
information across SNPs within a gene or a pathway in order
to increase the power to detect a gene or pathway level effect.
SNP-smoking interactions. We investigated SNP-smoking
interactions considering the following smoking variables:
smoking status (never, former, current), smoking intensity
(never, <20, 20 cigarettes per day), smoking duration
(never, <29, 29 years of smoking) and pack-years of smok-
ing (never, <24, 24 pack-years). Three-level variables were
generated using the median value among smoking controls as
a cut point for cigarettes per day, years of smoking and
pack-years. Interactions between SNPs and exposures were
investigated on a multiplicative scale using conditional logis-
tic models, assuming a log-additive mode of risk and using
likelihood ratio tests that included product terms between
each tagSNP and a three-level exposure variable coded with
dummy variables. Tests of trend across categories of exposure
were conducted by assigning median values to every tertile of
exposure and modeling the categories as continuous. Interac-
tion between SNPs and smoking status assumed that smoking
status (never 5 0, quit 5 1, current 5 2) was a categorical
variable in the interaction model, while the p-values for trend
Table 1. Characteristics of non-Hispanic whites in Los Angeles County and Shanghai Chinese
Los Angeles County Shanghai
Cases Controls Cases Controls
n 5 456 n 5 480 n 5 532 n 5 524
Mean age at enrollment (SD) 56 (67) 56 (68) 63 (610) 64 (610)
Age at enrollment (y)
45 51 (11%) 62 (13%) 51 (10%) 43 (8%)
45–49 54 (12%) 57 (12%) 30 (6%) 17 (3%)
50–54 83 (18%) 93 (19%) 38 (7%) 25 (5%)
55–59 138 (30%) 128 (27%) 43 (8%) 63 (12%)
60–64 129 (28%) 104 (22%) 137 (26%) 116 (22%)
>65 1 (0%) 35 (7%) <0.001 233 (44%) 260 (50%) 0.016
Gender
Male 357 (78%) 374 (78%) 421 (79%) 404 (77%)
Female 99 (22%) 106 (22%) 0.890 111 (21%) 120 (23%) 0.424
Smoking status
Never 83 (18%) 183 (38%) 178 (33%) 233 (44%)
Former 173 (38%) 212 (44%) 75 (14%) 84 (16%)
Current 200 (44%) 85 (18%) <0.001 279 (52%) 207 (40%) <0.001
Smoking intensity (cigarettes/day)
Never 83 (18%) 183 (38%) 178 (33%) 233 (44%)
<20 75 (16%) 88 (18%) 164 (31%) 155 (30%)
20 298 (65%) 209 (44%) <0.001 190 (36%) 136 (26%) <0.001
Smoking duration (years)
Never 83 (18%) 183 (38%) 178 (33%) 233 (45%)
<29 162 (36%) 190 (40%) 106 (20%) 101 (19%)
29 211 (46%) 107 (22%) <0.001 248 (47%) 190 (36%) 0.001
Pack-years of smoking
Never 83 (18%) 183 (38%) 178 (33%) 233 (44%)
<24 pack-years 116 (25%) 151 (31%) 155 (29%) 142 (27%)
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were calculated assuming smoking status as continuous in
the interaction model.
Similar to our hierarchical approach for multiple testing
correction for SNP main effects, within each gene region,
crude interaction p-values for each SNP (interaction pcrude)
were adjusted using a Bonferroni correction (PACT supports
multiple tests of SNP main effects but not multiple tests of
SNP by exposure interactions) that considered the number of
SNPs investigated within each corresponding gene region
(interaction pgene). These corrected interaction p-values were
further adjusted using a Bonferroni correction for the num-
ber of gene regions within each specific pathway (interaction
ppathway). Finally, these corrected interaction p-values were
further adjusted using Bonferroni for pathway-wide signifi-
cance (interaction poverall), considering that a total of four
pathways had been investigated. In all levels of correction,
statistical significance was declared if corrected p-values were
<0.05. All statistical tests conducted were two sided and all
analyses were performed using Stata 11/SE (Stata Corpora-
tion, College Station, TX) and the statistical package R 2.15
(The R Project for Statistical Computing, http://www.r-pro-
ject.org).
Results
Characteristics of cases and controls are summarized in Table
1. Briefly, males accounted for approximately 80% of study
participants in both Los Angeles County and Shanghai. Mean
age at enrollment for cases was 56 years of age in Los
Angeles County and 64 years of age in Shanghai. While 44%
of Shanghai cases were older than 65 years of age, less than
1% of Los Angeles cases were older than 65 years of age.
Reported rates of cigarette smoking were higher among Los
Angeles County cases and controls than among Shanghai
cases and controls.
DNA repair SNPs and bladder cancer risk
We investigated associations between DNA repair tagSNPs
and bladder cancer risk among NHW from the LABCS and
Chinese from the SBCS, separately and combined. Among
the 545 tagSNPs investigated among NHW in the LABC
study 21 showed statistically significant associations with
bladder cancer (pcrude < 0.05); however, none remained sig-
nificant after within gene region correction (pACT > 0.05).
None of these 21 tagSNPs showed statistically significant
associations among Shanghai Chinese (Supporting Informa-
tion Table 1).
Among the 542 tagSNPs investigated among Shanghai
Chinese, 30 tagSNPs were statistically significantly associated
with bladder cancer (pcrude < 0.05), and five of them
remained statistically significant after multiple comparisons
adjustment within gene region (PACT < 0.05): one in the
POLB gene (rs7832529, OR 5 1.5; 95% CI 5 1.2–1.9; pACT
5 0.003), one in the POLD1 gene (rs2244095, OR 5 0.8;
95%CI 5 0.6–0.9; pACT 5 0.025) and three in the XPC gene
(rs2607734, OR 5 1.3, 95% CI 5 1.1–1.6, pACT 5 0.020;
rs2279017, OR 5 1.3; 95%CI 5 1.1–1.6, pACT 5 0.024;
rs2228001, OR 5 1.3, 95%CI 5 1.1–1.6, pACT 5 0.028)
(Table 2).
Among the 469 tagSNPs investigated among the LABC
and SBC combined, 24 tagSNPs showed statistically signifi-
cant associations with bladder cancer (pcrude < 0.05). Only 3
tagSNPs—the same ones we observed to be associated among
Shanghai Chinese from the SBCS—remained statistically sig-
nificant after multiple comparisons adjustment within gene
region (pACT < 0.05): one in the POLB gene (rs7832529, OR
5 1.5, 95% CI 5 1.2–1.9, pACT 5 0.003) and two in the
POLD1gene (rs2244095, OR 5 0.8, 95% CI 5 0.7–0.9, pACT
5 0.018; rs2546551, OR 5 0.8, 95% CI 5 0.7–0.9, pACT 5 0.049)
genes (Table 2). Of these three SNPs, only one remained stat-
istically significant when correcting for all genes within the
corresponding pathway (BER) and showed a borderline sig-
nificant association when correcting for all pathways consid-
ered (POLB rs7832529 pACT 5 0.003; ppathway 5 0.021; poverall
5 0.084). None of these three tagSNPs showed statistically
significant heterogeneity by racial groups (NHW versus Chi-
nese); results among Chinese and NHW were of similar mag-
nitude and direction but were statistically significant only
among Chinese. Conversely, the three tagSNPs in the XPC
gene found to be statistically significantly associated with
bladder cancer risk among Chinese showed heterogeneity by
race (rs2607734 heterogeneity p 5 0.041; rs2279017 heteroge-
neity p 5 0.044; rs2228001 heterogeneity p 5 0.058), with the
association being restricted to Chinese.
DNA repair SNPs and smoking interactions
We conducted gene by smoking interaction analyses among
NHW and Chinese combined. None of the SNPs previously
identified to associate with bladder cancer risk (Table 2) were
found to modify the risk of smoking on bladder cancer.
XRCC6 (rs2284082), XPA (rs7853179), XRCC3 (rs709400)
and DCLRE1C (rs1079622) were found to modify the effect
of smoking across different measures of exposure, with inter-
action test p-values that achieved statistical significance
within each gene, but not at the pathway level (Table 3). The
only exception was XRCC6 SNP rs2284082 (NHEJ pathway),
which showed an interaction that achieved within gene
region and within pathway and overall pathway statistical sig-
nificance (Table 4). Specifically, among carriers of one (CT)
or two (CC) copies of the major allele C, statistically signifi-
cant trends were observed for the associations between smok-
ing pack-years, years of smoking, cigarettes per day and
smoking status, with greater strengths of association for CC
carriers than CT carriers. Instead, among carriers of two cop-
ies of the minor allele T (TT), non-statistically significant
positive trends, with reduced estimates, were observed (Table
4). For all smoking variables considered, except cigarettes per
day, tests of interaction remained statistically significant after
correction for multiple testing at the gene and pathway levels
(Smoking pack-years interaction pgene 5 0.003, ppathway 5










Corral et al. 339
Int. J. Cancer: 135, 335–347 (2014) VC 2014 UICC















29 NHEJ XRCC6 rs2284082 0.001 0.008 0.046 0.185
NER XPA rs7853179 0.002 0.023 0.164 0.656
HR XRCC3 rs709400 0.003 0.036 0.250 0.999
Pack-years of
smoking
26 NHEJ XRCC6 rs2284082 <0.001 0.003 0.020 0.079
NHEJ DCLRE1C rs10796227 0.002 0.033 0.199 0.794
Cigarettes per
day
8 NHEJ XRCC6 rs2284082 0.015 0.093 0.556 1.000
Smoking
Status
35 NHEJ XRCC6 rs2284082 <0.001 0.001 0.008 0.034
HR XRCC3 rs709400 0.002 0.025 0.177 0.706
NER XPA rs7853179 0.003 0.048 0.338 1.000
NHEJ DCLRE1C rs10796227 0.004 0.050 0.302 1.000
Table 2. SNPs associated with bladder cancer risk in the Los Angeles-Shanghai study
Pathway Gene tagSNP MAF Ca Co OR1 LCI UCI pcrude pACT ppathway poverall pHet
NHW (LABC)
BER POLB rs7832529 0.05 351 405 1.4 0.9 2.1 0.186 0.662 1.000 1.000
NER POLD1 rs2244095 0.11 353 407 0.9 0.6 1.2 0.473 0.884 1.000 1.000
NER POLD1 rs2546551 0.44 353 404 0.8 0.7 1.0 0.066 0.354 1.000 1.000
NER XPC rs2607734 0.43 355 409 1.0 0.8 1.3 0.857 1.000 1.000 1.000
NER XPC rs2279017 0.43 354 408 1.0 0.8 1.3 0.873 1.000 1.000 1.000
NER XPC rs2228001 0.43 352 409 1.0 0.8 1.3 0.773 1.000 1.000 1.000
Chinese (SBC)
BER POLB rs7832529 0.12 509 518 1.5 1.2 2.0 0.001 0.009 0.060 0.239
NER POLD1 rs2244095 0.35 513 514 0.8 0.6 0.9 0.004 0.025 0.173 0.693
NER POLD1 rs2546551 0.16 512 512 0.8 0.6 1.0 0.049 0.219 1.000 1.000
NER XPC rs2607734 0.36 514 520 1.3 1.1 1.6 0.002 0.020 0.141 0.562
NER XPC rs2279017 0.36 510 520 1.3 1.1 1.6 0.003 0.024 0.168 0.670
NER XPC rs2228001 0.36 513 521 1.3 1.1 1.6 0.004 0.028 0.197 0.788
NHW & Chinese (LABC & SBC)
BER POLB rs7832529 860 923 1.5 1.2 1.9 <0.001 0.003 0.021 0.084 0.564
NER POLD1 rs2244095 866 921 0.8 0.7 0.9 0.003 0.018 0.125 0.500 0.350
NER POLD1 rs2546551 865 916 0.8 0.7 0.9 0.009 0.049 0.342 1.000 0.676
NER XPC rs2607734 869 929 1.2 1.0 1.4 0.015 0.095 0.667 1.000 0.041
NER XPC rs2279017 864 928 1.2 1.0 1.4 0.018 0.111 0.778 1.000 0.044
NER XPC rs2228001 865 930 1.2 1.0 1.4 0.016 0.101 0.709 1.000 0.058
1Per allele ORs and 95% CIs estimated from conditional logistic regression models assuming a log-additive mode of risk and adjusting for smoking
status in reference year
LCI 5 95% lower confidence interval; UCI 5 95% upper confidence interval; pcrude 5 unadjusted for multiple testing p-value; pACT 5 p-value
corrected for multiple testing within gene region; ppathway 5 p-value corrected for multiple testing within gene region and within pathway; poverall 5
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0.046; smoking status interaction pgene 5 0.001, ppathway 5
0.008) (Table 4). Test of interaction for smoking status also
remained statistically significant when further correcting for
the total number of DNA repair pathways investigated
(smoking pack-years interaction poverall 5 0.032) (Table 4).
DNA repair SNPs by gender interactions
To explore possible heterogeneity of the SNP-bladder cancer
associations, we conducted stratified analysis by gender
among NHW, Chinese and among both sites combined
(Table 5). Among NHW males but not NHW females, we
observed inverse associations for three linked LIG1 SNPs
(rs2007183, rs20579 and rs3730912) with bladder cancer that
were statistically significant after within-gene-region correc-
tion (pACT < 0.05) and showed evidence of heterogeneity by
gender (pheterogeneity < 0.05) (Table 5).
Among Chinese, we observed three tagSNPs in the OGG1
gene that showed evidence of statistically significant heteroge-
neity by gender. These three SNPs were inversely associated
with bladder cancer risk only among females, and the associ-
ations remained statistically significant after within-gene cor-
rections, and for one of them remained significant after
pathway correction as well (rs6809452, OR 5 0.5; 95% CI 5
0.3–0.8, pACT 5 0.007, ppathway 5 0.046; rs1052133, OR 5
0.6, 95% CI 5 0.4–0.8, pACT 5 0.026; rs2072668, OR 5 0.6,
95% CI 5 0.4–0.9, pACT 5 0.049). Similar estimates were
observed among NHW females and among NHW and Chi-
nese females combined, but estimates did not reach statistical
significance (data not shown). We also observed that the pre-
viously observed associations of the POLB tagSNP
(rs7832529) and the 3 XPC tagSNPs (rs26077734, rs2228001
and rs2279017) with bladder cancer risk among all Chinese
individuals combined, plus an additional new XPC tagSNP
(rs2305843), seemed restricted to males, but tests of heteroge-
neity were not statistically significant (Table 5).
Similarly, among males in the combined study (NHW and
Chinese), three XPC tagSNPs (rs2305843 rs2607734 and
rs2228001) were statistically significantly associated with
bladder cancer risk. In addition, the previously observed asso-
ciation between the POLD1 tagSNPs (rs2546651 and
rs2244095) and bladder cancer risk among both races com-
bined seemed restricted to males. However, for neither of
these tagSNPs were tests of heterogeneity by gender statisti-
cally significant (Table 5).
Pathway analyses
We used the ARTP approach to obtain a summary p-value
for the association of each gene and pathway considered in
the study with bladder cancer risk (Table 6). Among NHW,
only LIG1 (NER pathway) achieved gene-wide statistical sig-
nificance among males. Instead, among Chinese, six genes
appeared associated with susceptibility to bladder cancer
achieving ARTP gene-wide significance, with four of them
showing heterogeneity by gender: OGG1 (Chinese females
pARTP gene 5 0.015), POLB (All Chinese pARTP gene 5 0.010,
Chinese males pARTP gene 5 0.048), RAD50 (All Chinese pARTP
gene 5 0.034, Chinese males pARTP gene 5 0.023), POLD1 (All Chi-
nese pARTP gene 5 0.021), XPC (All Chinese pARTP gene 5 0.017,
Chinese males pARTP gene 5 0.003) and finally XRCC6 (All Chi-
nese pARTP gene 5 0.010, Chinese females pARTP gene 5 0.043).
Three of these genes showed ARTP gene-wide significance when
all NHW and Chinese combined: POLB (Chinese & NHW pARTP
gene 5 0.013), RAD50 (Chinese & NHW pARTP gene 5 0.048),
POLD1 (Chinese & NHW pARTP gene 5 0.013) and XPC (Chinese
& NHW pARTP gene 5 0.045) (Table 6). When considering overall
pathway associations, we only observed an association of
pathway-wide significance for the NER pathway among Chinese
males (pARTP pathway 5 0.034), and we observed a pathway-wide
ARTP p-value of borderline significance when considering all
Chinese combined (pARTP pathway 5 0.068) (Table 6).
Discussion
In this study we investigated the association between a com-
prehensive SNP panel that captured genetic variation in
genes that play key roles in four different DNA repair path-
ways and bladder cancer risk. Our most consistent and key
findings were an association between POLB rs7832529 and
bladder cancer risk, predominantly among Chinese, an asso-
ciation between OGG1 rs6809452 and bladder cancer risk
among Chinese women only and an association between XPC
rs2607734 and bladder cancer risk among Chinese men only.
POLB and OGG1 play key roles in the BER pathway and
XPC participates in the NER pathway. Analyses that sum-
marized the effects of all SNPs within each gene, obtained
using the ARTP approach for both genders combined con-
firmed a role for POLB in bladder cancer risk among Chinese
and also indicated associations between RAD50 (HRR path-
way), POLD1 (NER pathway), XPC (NER pathway), LIG1
(NER pathway), OGG1 (BER pathway) and XRCC6 (NHEJ
pathway). However, when considering estimates that sum-
marized the effect of all genes within each of the four path-
ways, we observed only a statistically significant association
for the NER pathway among Chinese males and a borderline
statistically significant one among all Chinese combined.
When considering cigarette smoking variables we found con-
sistent evidence that the XRCC6 rs2284082 SNP (NHEJ path-
way) modified the effect of smoking. Estimates of interaction
for this SNP remained statistically significant after correction
for multiple testing within each gene, within the NHEJ path-
way and across all four pathways. None of the genes in the
other three pathways showed strong evidence of effect modi-
fication by smoking. Altogether, these findings suggest that
among Chinese, particularly men, there are bladder cancer
risk factors, other than smoking, that elicit the BER and NER
pathways and may play key roles in bladder cancer forma-
tion. Alternatively, they suggest that presence of these genetic
variants, may predispose individuals to developing bladder
cancer, independently of environmental exposures, perhaps
due to loss over time of DNA repair proficiency and inability
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Finally, our findings support a role for the NHEJ pathway in
smoking-induced bladder cancer risk, suggesting that among
all types of damage induced by tobacco carcinogens, double
strand breaks seem to be the ones more detrimental for can-
cer risk. In support of this, two other NHEJ genes (DCLRE1C
and XRCC3) were also found to modify the effect of smok-
ing, although findings were not as significant as for XRCC6.
The number of variants and genes investigated in DNA
repair pathways in association with bladder cancer risk has
been limited. In collaboration with the International Consor-
tium of Bladder Cancer Studies, we previously published a
meta-analysis and pooled analyses of 10 common variants in
seven genes and reported that three SNPs (ERCC2 rs1799793,
NBN rs1805794 and XPC rs2228000) were associated with a
modest increase in bladder cancer risk.14 GWAS, meta-
analysis of GWAS and pathway-based analysis of GWAS
have identified multiple loci associated with bladder cancer
susceptibility in subjects of European ancestry.23–29 Whereas
several SNPs located in carcinogen metabolism enzyme cod-
ing genes have achieved genome-wide significance, no SNPs
located in DNA repair genes have achieved genome-wide sig-
nificance to date. We summarize below what is known about
Table 6. Gene- and pathway-level summary p-values from ARTP pathway analyses in LABCS and SBCS
ARTP Gene p-value ARTP Pathway p-value
NHW Chinese NHW Chinese
Pathway
Gene/
Region All Females Males All Females Males
Combined
All All Females Males All Females Males
Combined
All
BER 0.746 0.443 0.4845 0.356 0.143 0.329 0.724
APEX1 0.926 0.932 0.898 0.831 0.920 0.791 0.926
LIG3 0.431 0.061 0.904 0.834 0.891 0.767 0.474
NEIL1 0.633 0.727 0.712 0.881 0.922 0.724 0.894
OGG1 0.674 0.678 0.812 0.225 0.015 0.556 0.486
PARP1 0.170 0.650 0.066 0.895 0.085 0.761 0.628
POLB 0.416 0.248 0.980 0.010 0.262 0.048 0.013
XRCC1 0.736 0.252 0.828 0.209 0.887 0.116 0.694
HRR 0.554 0.587 0.784 0.510 0.772 0.219 0.676
MRE11A 0.272 0.239 0.285 0.805 0.589 0.849 0.566
NBN 0.380 0.310 0.366 0.471 0.718 0.651 0.795
RAD50 0.591 0.189 0.871 0.034 0.824 0.023 0.048
RAD51 0.214 0.923 0.196 0.930 0.965 0.970 0.402
RAD52 0.967 0.488 0.959 0.821 0.622 0.946 0.935
XRCC2 0.154 0.267 0.466 0.779 0.155 0.978 0.276
XRCC3 0.384 0.872 0.877 0.321 0.395 0.255 0.664
NER 0.649 0.672 0.234 0.068 0.293 0.034 0.107
ERCC1-ERCC2 0.682 0.824 0.740 0.133 0.161 0.193 0.087
ERCC4 0.312 0.2105 0.918 0.069 0.160 0.267 0.487
ERCC5 0.177 0.7625 0.181 0.332 0.916 0.462 0.360
LIG1 0.139 0.3745 0.025 0.716 0.302 0.795 0.942
POLD1 0.430 0.4705 0.315 0.021 0.057 0.105 0.013
XPA 0.956 0.1245 0.985 0.915 0.491 0.806 0.886
XPC 0.563 0.9705 0.440 0.017 0.941 0.003 0.045
NHEJ 0.598 0.182 0.698 0.236 0.206 0.774 0.397
DCLRE1C 0.975 0.190 0.7845 0.728 0.216 0.942 0.717
LIG4 0.715 0.241 0.841 0.908 0.711 0.935 0.841
PRKDC 0.587 0.352 0.7015 0.789 0.298 0.840 0.540
XRCC4 0.104 0.125 0.140 0.174 0.247 0.315 0.129
XRCC5 0.768 0.629 0.678 0.292 0.333 0.280 0.595
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the genetic regions for which we found stronger evidence of
an association with bladder cancer risk (XPC, POLB, OGG1
and POLD) and evidence of interaction with smoking
(XRCC6).
Our pathway-based analyses point to the NER pathway as
relevant for bladder cancer risk. Associations between SNPs
in the XPC and POLD1 genes among Chinese seemed to be
responsible for the overall observed association with this
pathway. NER is involved in the repair of bulky DNA
adducts, such as those induced by tobacco smoke carcino-
gens.30 The xeroderma pigmentosum complementation group
C gene (XPC) (HGNC 12816) is located on chromosome
3p25. XPC detects and binds to DNA adducts and initiates
recruitment of other NER pathway proteins at the site of
damage.31,32 Our individual SNP analyses and overall gene
analyses suggested an association between bladder cancer risk
and XPC. Pooled analyses of most available epidemiological
studies with data on selected XPC polymorphisms, including
ours, showed an association for XPC rs2228000 with bladder
cancer risk among NHW and no association with SNP
rs2228001.14 In this study, we could not replicate the associa-
tion with rs2228000 among NHW or Chinese; however, we
report a statistically significant association between XPC
rs2228001 and bladder cancer risk among Chinese males.14
The functional relevance/biological mechanism of the variant
is unknown. There are two 30UTR SNPs nearby that have
been reported to affect XPC protein expression: rs2470352
and rs247045833; however, neither of these SNPs are in LD
with rs2228001.
Our individual SNP analyses and overall gene analyses
also indicated an association between POLD1 and bladder
cancer risk, which seem stronger among men. The polymer-
ase (DNA directed), delta 1, catalytic subunit gene (POLD)
(HGNC: 9175) is located on chromosome 19q13 and encodes
the catalytic and proofreading subunit of Pol d, which has
polymerase and 30-exonuclease activity.34 We report associa-
tions with bladder cancer risk for two SNPs: rs2546551, an
intronic SNP and rs2244095 SNP, which is 30-downstream of
POLD, within the Spi-B transcription factor (Spi-1/PU.1
related) gene (SPIB) (HGNC: 11242). Both SNPs are
unlinked among Chinese and among NHW (HapMap
CHBJPT r2 5 0.22, D’ 5 0.93; CEU r2 5 0.12, D’ 5 1.00).
These SNPs are not linked with previously SNPs investigated
in relation to bladder cancer risk, for which no associations
were reported.35–37
We found that SNP rs7832529 in POLB associated with
bladder cancer risk, mostly among Chinese. Summary esti-
mates at the gene level using ARTP supported this finding.
The polymerase (DNA directed) beta gene (POLB) (HGNC:
9174) is located on chromosome 8p11 and encodes a DNA
polymerase involved in short patch and long patch BER.38
Bladder cancer tumors and cell lines frequently encounter
deletions in chromosomal region 8p, with 8p11-12 being one
of the affected regions.39 Located 30-downstream from POLB,
SNP rs7832529 is actually located within the solute carrier
family 20 (phosphate transporter), member 2 gene
(SLC20A2) (HGNC: 10947). To our knowledge, SLC20A2 has
not been linked with bladder cancer. Several other POLB
SNPs have been reported to be associated with bladder can-
cer risk among Caucasians, but neither are in LD with
rs7832529.37,40 It remains to be determined whether
rs7832529 is tagging a causal SNP in POLB or SLC20A2.
We also report that three OGG1 SNPs (rs2072668,
rs6809452 and rs1052133) were inversely associated with
bladder cancer risk among Chinese females, with a stronger
association for rs6809452. The 8-oxoG DNA glycosylase1
gene (OGG1) (HGNC: 12816) is located on chromosome
3p26.41 The OGG1 protein participates in the removal of 8-
oxoguanine (8-oxo-G) DNA damage that can result from
ROS exposure. The intronic OGG1 rs2072668 and rs6809452
SNPs were in strong LD with the non-synonymous and puta-
tive functional OGG1 Ser326Cys SNP (rs1052133) (HapMap
CHBJPT r2 5 0.98, D’ 5 1.00 for rs2072668 and r2 5 0.88,
D’ 5 1.00 for rs6809452). SNP rs6809452, for which we
found the strongest association, is actually an intronic SNP
within the transcriptional adapter 3-like gene (TADA3L). The
OGG1 Ser326Cys rs1052133 Cys allele has been reported to
code for a protein with decreased ability to repair oxidative
DNA damage.42–46 A meta-analysis of various cancers
reported that Ser326Cys was significantly associated with
overall cancer risk and lung cancer risk but was not associ-
ated with bladder cancer risk.47 Three epidemiological studies
have reported associations between this SNP and bladder
cancer risk among Caucasians, with stronger associations
among smokers.35–37
Finally, we observed strong evidence that one SNP in the
XRCC6 gene, rs22284082, modified the effect of cigarette
smoking. We found that among carriers of one or two copies
of the C allele (major allele) there was a stronger and more
significant association with tobacco smoking that among car-
riers of two copies of the T allele. The X-ray repair comple-
menting defective repair in Chinese hamster cells 6 gene
(XRCC6) (HGNC: 4055) is on chromosome region 22q13.
SNP rs22284082 is located 30-downstream from XRCC6 and
it maps to the sterol regulatory element binding transcription
factor 2 gene (SREBF2) (HGNC: 11290), in intron 1. SRBF2
encodes a transcription factor SREBP-2, a basic helix-loop-
helix-leucine zipper protein that can stimulate transcription
of sterol regulated genes and monitor lipid homeostasis.48 In
addition, SREBP-2 can also regulate autophagy related genes
in times of nutrient depletion.49 SREBF2 has not been investi-
gated in relation with bladder cancer; however, it has been
reported to be involved in the loss of sterol feedback regula-
tion in cancer cells.50 It remains to be determined if the
interaction with smoking we see for this SNP is capturing an
effect of a causal SNP in XRCC6 or SREBF2.
Our study had several strengths. Among them, was the
use of two population-based case-control studies conducted
in parallel in two world regions with contrasting bladder can-
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smoking exposure. Another one is the use of a comprehen-
sive tagSNP approach that captured 85–100% genetic varia-
tion in genes that play key roles in four major DNA repair
pathways, with appropriate consideration of multiple testing.
Although we recognize that our tagSNP selection was done
before the release of the 1,000 genomes project, which
includes rare variants. Therefore, compared to this reference
database, our overall genetic coverage would be lower.
Finally, given that most studies on DNA repair susceptibility
genes and bladder cancer have been conducting among
NHW, our study contributes novel data about genetic risk
factors among Chinese. Among the limitations of our study
we include the fact that not all DNA repair genes from each
pathway were captured, albeit all those that play essential
roles were included and the fact that we were underpowered
to explore higher order interactions between genes and expo-
sures. Lastly, in spite of our approaches for multiple testing
correction, we cannot discard the possibility that some of our
findings might be false positives. Replication in other studies
will help confirm our findings.
In conclusion, we found support that two regions that
map close to or within BER genes (POLB, OGG1) and one
region in an NER gene (XPC) are associated with bladder
cancer risk, primarily among Chinese. Given that these asso-
ciations were not modified by smoking, they suggest that
there are other environmental factors that elicit the BER and
NER pathways and might be relevant bladder cancer risk fac-
tors. We also find evidence that one SNP that tags both the
XRCC6 and SREBF2 genes strongly modifies the association
between bladder cancer risk and tobacco smoke. Given the
role XRCC6 plays in the NHEJ pathway, this finding suggests
that tobacco smoking may induce bladder cancer through the
formation of double strand breaks. Further investigation in
independent study populations will help confirm these find-
ings and guide future studies to identify the causal variants
responsible for these associations and all the relevant expo-
sures that elicit the action of these DNA repair pathways.
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